Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug
by Rishma Parpia
Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit ...
Moderna CEO Was Paid $18.2 Million in 2021
by Natasha Hobley
As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent ...
Pfizer CEO Received $24.3 Million in Total Compensation for 2021
by Natasha Hobley
Pfizer CEO Albert Bourla, who recently announced that a fourth COVID-19 vaccine dose will be necessary for everyone who has ...
U.S. Consumers Warned About Fraudulent Coronavirus Testing Sites
by Rishma Parpia
The U.S. Department of Health and Human Services Office of Inspector General has issued a warning to the public about ...
Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study
by Rishma Parpia
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as "Comirnaty") messenger RNA ...
Pharmaceutical Industry Reaping Billions of Dollars in Profits from Coronavirus Tests
by Rishma Parpia
Since the beginning of the COVID-19 pandemic, public health officials have urged widespread testing for the presence of the SARS-CoV-2 ...
Sales of Pfizer COVID-19 Biologic for 2021-2022 May Near $70 Billion
by TVR Staff
Based on better than expected sales of its experimental messenger RNA (mRNA) BNT162b2 COVID-19 biologic, New York-based pharmaceutical company Pfizer, ...
Former Pfizer Employee Whistleblower Alleges Falsified Data in COVID Biologic Trial
by Natasha Hobley
A former testing site researcher in Texas has alleged that Pfizer’s pre-licensure BNT162b2 (also known as "Comirnaty") COVID-19 biologic trials ...
Merck and Pfizer Seek Approval for COVID-19 Antiviral Drugs
by Rishma Parpia
Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize ...
In this section
Latest
Popular
Comments
Latest
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
by Amber Baker and Barbara Loe Fisher
Popular
Comments
Michelle K Wood on FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
Steve Thomas on Oral Rabies Vaccine Deployed by Air to Vaccinate Wildlife in Vermont
Andrea on Oral Rabies Vaccine Deployed by Air to Vaccinate Wildlife in Vermont
Informed Consent on Government Cancels $700 Million in Funding for Moderna’s Bird Flu Biologic
